talquetamab,belantamab mafodotin
gsk,janssen
['mmsm', 'monumental-1', 'belantamab', 'talquetamab']
#ash22 #mmsm monumental-1 important slide, those are results after failure of bcma drug. responses are good overall. dor is lower at around 13 mo. 
Assistant professor @UAMSMyeloma. Alumni heme/onc @bcmhouston, clinical research/biostat @UMich.Focus on plasma cell disorders & health disparities